Dian Zhou
#84 West Huaihai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Safety and Efficacy of Beraprost Sodium Combined with Negative Pressure Drip Irrigation in the Treatment of Diabetic Foot Ulcer: A Retrospective Cohort Study.
Journal: The international journal of lower extremity wounds
Published: March 24, 2026
A proliferation-inducing ligand enhances the anti-tumor effect of BCMA CAR T-cell through inhibition of soluble BCMA.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 16, 2026
Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis.
Journal: BMC medicine
Published: February 07, 2026
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.
Journal: Blood
Published: February 03, 2026
The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy.
Journal: Frontiers in immunology
Published: January 24, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: November 30, 2024
Targeting GPRC5D for multiple myeloma therapy.
Journal: Journal of hematology & oncology
Published: August 13, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial.
Journal: The Lancet. Haematology
Published: March 10, 2024
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2023
Retraction Note: Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma.
Journal: Molecular and cellular biochemistry
Published: October 13, 2022
Last Updated: 09/26/2026